Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02939183 · COMPLETED
Trial details
- NCT number
- NCT02939183
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2022-10-06
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.